原发性失眠患者团体认知行为治疗的随机对照试验  

A randomized controlled trial of group cognitive behavioral therapy in patients with primary insomnia

作　　者：徐莲莲[1] 薛闯[1] 胡霖霖[1] 徐悠 尹岩[1] 余正和[1] 唐文新[1] 毛洪京[1] XU Lianlian;XUE Chuang;HU Linlin;XU You;YIN Yan;YU Zhenghe;TANG Wenxin;MAO Hongjing(The Seventh Hospital of Hangzhou,Hangzhou 310013,China)

机构地区：[1]杭州市第七人民医院精神科,杭州310013

出　　处：《中国心理卫生杂志》2020年第12期971-976,共6页Chinese Mental Health Journal

基　　金：杭州市科技发展计划项目——团体认知行为治疗对原发性失眠患者睡眠结构及持续性注意力的影响(20170533B53)。

摘　　要：目的:探讨团体认知行为治疗(GCBT)对原发性失眠患者的疗效。方法:原发性失眠患者94例,随机分为GCBT组(n=48)和非GCBT对照组(n=46)。GCBT组开展为期12周的GCBT(每周1次,每次2 h),对照组每周1次心理健康讲座。在基线与12周后对2组进行匹兹堡睡眠质量问卷(PSQI)及多导睡眠监测(PSG)测评。结果:12周治疗后,除催眠药物因子外, GCBT组PSQI评分均低于对照组及基线期(均P<0.05);GCBT组在睡眠总时间、睡眠效率、非快速眼动睡眠(NREM)Ⅲ期及快速眼动睡眠期占比均高于对照组,睡眠潜伏期、入睡后觉醒时间、NREMⅠ期占比均低于对照组及基线期(均P<0.05)。结论:团体认知行为治疗能缓解原发性失眠患者的失眠症状,改善患者的睡眠结构。Objective:To explore the effect of group cognitive behavioral therapy(GCBT) in patients with primary insomnia.Methods:Ninety-four patients with primary insomniawere randomly divided to the GCBT group(n=48) and the non-GCBT group(n=46,control group).The GCBT group attended GCBT for 12 weeks(once a week,and 2 hours every time),and the control group attended the lecture on mental health altogether every week.All the participants were measured at baseline and 12 weeks later respectively with the Pittsburgh Sleep Quality Index Scale(PSQI) and Polysomnography(PSG).Results:Except for hypnotic factor,the scores of PSQI in the GCBT group 12 weeks later were lower than those in the control group and at baseline(Ps<0.05).The parameters of total sleep time,sleep efficiency,NREMⅢ and REM sleep period in the GCBT group were higher than those in the control group,while sleep latency,wake after sleep onset,NREMⅠperiod in the GCBT group were lower than those in the control group and at baseline(Ps<0.05).Conclusion:It suggests that group cognitive behavioral therapy may relieve insomnia symptoms in patients with primary insomnia and improve their sleep structure.

关 键 词：原发性失眠 团体认知行为治疗 疗效 多导睡眠监测 

分 类 号：R749.059[医药卫生—神经病学与精神病学] R338.63[医药卫生—临床医学]